*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Timothy O’Shea, Ph.D.
Postdoctoral Fellow
Departments of Neurobiology and Bioengineering
David Geffen School of Medicine
University of California, Los Angeles
Wednesday, January 30, 2019
10:00 a.m. – 11:00 a.m.
Emory University, Health Sciences Research Building (HSRB)
Room E160
Videoconference:
Georgia Tech: UAW 3115/ Georgia Tech: TEP 208
https://bluejeans.com/809850842
ABSTRACT
Following traumatic injury to the adult central nervous system (CNS), neural connectivity is lost and fails to spontaneously regrow. This regeneration failure may be due to an intrinsic inability for damaged neurons to regrow in the adult as well as the formation of a stromal and inflammatory cell laden non-neural lesion core that is devoid of essential axon growth cues. The first part of this talk dissects the cell biology of traumatic CNS injury lesions and demonstrates that stimulating axons to regrow after injury requires the sequential re-activation of neuronal growth capacity and the reintroduction of essential molecular factors not present in CNS lesion compartments. The second part of the talk will outline how the grafting of neural progenitor cells into CNS lesions may be used to provide long-term support to stimulated axon regeneration paradigms. The last part of the talk will describe the development of an immunohistochemical framework to evaluate the multicellular CNS foreign body response to biomaterials and how various properties of biomaterials can be manipulated to improve the functionality of these tools in bioengineered neural repair strategies.
BIOGRAPHY
Timothy O’Shea is a Postdoctoral Fellow in Neurobiology at UCLA. He completed his PhD study in Medical Engineering and Medical Physics within the collaborative Health Sciences and Technology program of the Harvard Medical School and the Massachusetts Institute of Technology. Tim conducted PhD thesis research with Institute Professor Robert Langer developing injectable biomaterials to improve the delivery of reparative therapies for the treatment of various central nervous system (CNS) diseases. At UCLA he works with Professors Michael Sofroniew (Neurobiology) and Timothy Deming (Bioengineering) developing and testing novel bioengineering tools to study biological mechanisms involved in CNS injury and repair. He has held research fellowships from the Sir John Monash Foundation, the Society of Chemical Industry, the Craig H. Neilsen Foundation, Paralyzed Veterans of America and American Australian Association. His research has been published in Nature, JCI, Cell Reports, JACS, Advanced Materials, Biomaterials and other leading journals.
Host: Michelle LaPlaca
